ReNeuron Group PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP42.25 |
Market Cap |
GBP73.15 M |
Shares Outstanding |
31.8 M |
Public Float |
30.53 M |
Address |
Pencoed Business Park Pencoed BJ CF35 5HY United Kingdom |
Employees | - |
Website | http://reneuron.com |
Updated | 07/08/2019 |
ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom. |